MedTrace Logo

Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation

NCT07426068 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-02-23

No results posted yet for this study

Summary

This study aims to apply autologous differentiated myocyte subcutaneous transplantation in patients with muscle atrophy to explore its safety, feasibility, and efficacy.

Conditions

  • Metabolic Disease
  • Amyotrophy

Interventions

BIOLOGICAL

Autologous differentiated myocyte transplantation

Autologous differentiated myocytes will be prepared from each participant and transplanted subcutaneously. All enrolled participants will receive the same intervention and will be followed longitudinally for safety, feasibility, and outcome assessments.

Sponsors & Collaborators

  • National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Chinese PLA General Hospital

    collaborator UNKNOWN

  • National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Binhai Yangshi Orthopedic Hospital

    collaborator UNKNOWN

  • National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China

    lead NETWORK

Principal Investigators

  • Pengbin YIn · National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2028-02-01
Completion
2028-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07426068 on ClinicalTrials.gov